Send me real-time posts from this site at my email
Motley Fool

Why TG Therapeutics Is Plunging More Than 40% Today

Investors are rattled by the FDA's request for an out-of-the-ordinary meeting dedicated to scrutinizing the company's latest drug approval request.

Popular posts

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue